Suppr超能文献

结直肠癌肝转移患者未来肝残余量调节后腹腔镜右半肝或扩大右半肝切除术的安全性和可行性:一项系统评价

Safety and Feasibility of Laparoscopic Right or Extended Right Hemi Hepatectomy Following Modulation of the Future Liver Remnant in Patients with Colorectal Liver Metastases: A Systematic Review.

作者信息

Bozkurt Emre, Sijberden Jasper P, Abu Hilal Mohammad

机构信息

Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.

Hepatopancreatobiliary Surgery Division, Department of Surgery, Koç University Hospital, Istanbul, Turkey.

出版信息

J Laparoendosc Adv Surg Tech A. 2023 Jul;33(7):654-664. doi: 10.1089/lap.2022.0609. Epub 2023 Apr 4.

Abstract

Major hepatectomies after future liver remnant (FLR) modulation are technically demanding procedures, especially when performed as minimally invasive surgery. The aim of this systematic review is to assess current evidence regarding the safety and feasibility of laparoscopic right or extended right hemihepatectomies after FLR modulation. The Medline, PubMed, Cochrane Library, and Embase databases were searched for studies involving laparoscopic right or extended right hemihepatectomies after FLR modulation, from their inception to December 2021. Two reviewers independently selected eligible articles and assessed their quality using the Newcastle-Ottawa Quality Assessment Scale (NOS). Baseline characteristics and outcomes were extracted from the included studies and summarized. Six studies were included. In these studies, the median length of stay after the second stage ranged from 4.5 to 15.5 days and postoperative complication rates between 4.5% and 42.8%. Overall, 7.4% of patients developed liver failure, and 90-day mortality occurred in 3.2% of patients. The R0 resection rate was 93.5%. Only one study reported long-term outcomes, describing comparable 3-year overall survival rates following laparoscopic and open surgery (80% versus 54%,  = .154). The current evidence is scarce, but it suggests that in experienced centers, laparoscopic right or extended right hemihepatectomy, following FLR modulation, is a safe and feasible procedure.

摘要

在对未来肝脏残余量(FLR)进行调节后实施的大范围肝切除术是技术要求很高的手术,尤其是在进行微创手术时。本系统评价的目的是评估有关FLR调节后腹腔镜下右半肝切除术或扩大右半肝切除术的安全性和可行性的现有证据。检索了Medline、PubMed、Cochrane图书馆和Embase数据库,以查找从创立至2021年12月涉及FLR调节后腹腔镜下右半肝切除术或扩大右半肝切除术的研究。两名评价者独立选择符合条件的文章,并使用纽卡斯尔-渥太华质量评估量表(NOS)评估其质量。从纳入的研究中提取基线特征和结果并进行总结。共纳入6项研究。在这些研究中,第二阶段术后中位住院时间为4.5至15.5天,术后并发症发生率在4.5%至42.8%之间。总体而言,7.4%的患者发生肝衰竭,3.2%的患者出现90天死亡率。R0切除率为93.5%。只有一项研究报告了长期结果,描述了腹腔镜手术和开放手术后3年总生存率相当(80%对54%,P = 0.154)。目前证据不足,但表明在有经验的中心,FLR调节后腹腔镜下右半肝切除术或扩大右半肝切除术是一种安全可行的手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验